by 2nd Smartest Guy in the World, 2nd Smartest Guy in the World:
This Substack has recently reviewed the issue of Graphene Oxide in the slow kill bioweapon injections in conjunction with the modified Spike Proteins, or SP 2:
BOMBSHELL UPDATE: FDA confirms Modified Spike Protein used in mRNA COVID-19 “Vaccines” is NOT Safe & More Dangerous than Unmodified Spike Protein after being Forced to Publish Confidential Pfizer Docs
In an even deeper dive on the presence of Graphene Oxide in these “vaccines” we now have irrefutable proof that all of the BigPharma DEATHVAX™ manufacturers on behalf of their coconspirators the DoD, Pentagon, et al. included this cytotoxic ingredient. An ingredient, mind you, that has nothing to do with prevention, transmissibility or attenuation of PSYOP-19 symptoms, and in no way preserves, improves, or adds any benefit to the actual products.
In the summer of 2021 Dr. Campras and his team analyzed four different PSYOP-19 “vaccines:” Pfizer-BioNtech’s Comirnaty, Astrazeneca’s Vaxzevria, Johnson & Johnson’s Janssen, and Moderna’s.
These were their published findings:
In the case of the Pfizer-BioNtech vaccine (Comirnaty), an abundance of transparent 2D laminar objects were found, which, the company suggested, resemble Graphene Oxide. The images obtained from the vaccine sample were compared to images of graphene oxide from previous studies, and a standard reduced graphene oxide sample.
Using transmission electron microscopy, the laminar objects were further analyzed and similarities were found with graphene oxide imagery in scientific literature. The analysis had clearly demonstrated the presence of an intricate matrix or mesh of folded translucent flexible sheets with darker multilayer agglomerations and lighter unfolded monolayers.
A quantification of mRNA in the Comirnaty sample was also performed, showing that most of the absorbance in the sample might be due to these graphene-like sheets, suggesting a high concentration of this material.
The fluorescence measurements also aligned with the peak values for reduced graphene oxide.
This is probably the most convincing evidence in existence that the Graphene Oxide nanotechnology is a deliberate component of these injections, and the implications are horrifying.
The published findings of Dr. Campras’ analysees of Graphene Oxide in the vaccines:
We have carried out a random screening of graphene-like nanoparticles visible at the optical microscopy in seven random samples of vials from four different trademarks, coupling images with their spectral signatures of RAMAN vibration. By this technique, called micro-RAMAN, we have been able to determine the presence of graphene in some of these samples, after screening more than 110 objects selected for their graphene-like appearance under optical microscopy. Out of them, a group of 28 objects have been selected, due to the compatibility of both images and spectra with the presence of graphene derivatives, based on the correspondence of these signals with those obtained from standards and scientific literature. The identification of graphene oxide structures can be regarded as conclusive in 8 of them, due to the high spectral correlation with the standard. In the remaining 20 objects, images coupled with Raman signals show a very high level of compatibility with undetermined graphene structures, however different than the standard used here. This research remains open and is made available to scientific community for discussion. We make a call for independent researchers, with no conflict of interest or coaction from any institution to make wider counter-analysis of these products to achieve a more detailed knowledge of the composition and potential health risk of these experimental drugs, reminding that graphene materials have a potential toxicity on human beings and its presence has not been declared in any emergency use authorization.
Microscopic study of the sample provides strong evidence for the probable presence of graphene derivatives, although microscopy does not provide conclusive evidence. The definitive identification of graphene, oxidized graphene (GO) or reduced oxidized graphene (rGO) in the RD1 sample requires the STRUCTURAL CHARACTERIZATION through the analysis of specific spectral standard sample comparable to those published in literature and those obtained from the standard sample, obtained with spectroscopic techniques such as XPS, EDS, NMR, FTIR or Raman, among others.
Dr. Campras’ findings are presenting the most compelling data of the existence of Graphene Oxide in these injections.
It is important to appreciate that NO OFFICIAL COUNTER-ANALYSIS FROM REGULATORY AGENCIES has been done or published.
The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)
Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.
Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.
Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.